CN Patent

CN112386577B — 一种治疗便秘的组合物

Assigned to BEIJING TIANHENG DRUG RESEARCH INSTITUTE · Expires 2024-01-23 · 2y expired

What this patent protects

本发明提供了一种用于治疗便秘的组合物，所述组合物不含药物，包括有效量的高粘度亲水凝胶骨架材料、渗透压促进剂及其他药学上可接受的辅料、载体或赋形剂，通过选择合适的比例和用量制备成片剂，口服后，具有治疗缓解便秘的效果，副作用小。

USPTO Abstract

本发明提供了一种用于治疗便秘的组合物，所述组合物不含药物，包括有效量的高粘度亲水凝胶骨架材料、渗透压促进剂及其他药学上可接受的辅料、载体或赋形剂，通过选择合适的比例和用量制备成片剂，口服后，具有治疗缓解便秘的效果，副作用小。

Drugs covered by this patent

sodium-phosphate-dibasic-anhydrous (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS)

Patent Metadata

Patent number: CN112386577B
Jurisdiction: CN
Classification: —
Expires: 2024-01-23
Drug substance claim: No
Drug product claim: No
Assignee: BEIJING TIANHENG DRUG RESEARCH INSTITUTE
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.